by Eriksen Insurance | Jun 11, 2025 | Uncategorized
A noteworthy shift is unfolding in teen healthcare: the weight-loss drug Wegovy—a GLP‑1 therapy by Novo Nordisk—has seen a dramatic 50% rise in prescriptions among U.S. adolescents over the past year. 📊 By the Numbers In 2023, 9.9 teens per 100,000 began Wegovy...
by Eriksen Insurance | Jun 11, 2025 | Uncategorized
🚀 What’s Currently in Motion 15 high‑cost drugs under negotiation: This round includes heavyweights like Novo Nordisk’s Ozempic (used for type 2 diabetes) and Amgen’s Otezla (for psoriasis and arthritis). Both companies have received initial pricing offers from...
by Eriksen Insurance | May 23, 2025 | Uncategorized
Recent federal budget reductions have significantly affected the landscape of public health and scientific research in the United States. These cuts have led to the termination of numerous grants and programs, with potential long-term consequences for healthcare and...
by Eriksen Insurance | May 14, 2025 | Uncategorized
Navigating Mental Health & Substance Use Disorder Coverage with Medicare Mental health and substance use disorders affect millions of Americans every year—and for those on Medicare, getting the right support matters. Whether you’re managing anxiety, depression,...
by Eriksen Insurance | May 12, 2025 | Uncategorized
As 2026 approaches, Medicare is set to implement several significant changes aimed at enhancing affordability, simplifying processes, and improving care for beneficiaries. These updates, stemming from the Inflation Reduction Act of 2022 and recent policy adjustments,...
by Eriksen Insurance | Apr 1, 2025 | Uncategorized
Having worked on reorganizing both nonprofit and public sector organizations, I have a few reflections on Secretary Robert F. Kennedy Jr.’s restructuring of the Department of Health and Human Services (HHS). With my early career experience at HHS, I have a solid...
